940 results about "Fluid composition" patented technology

A device and method for applying a fibrinogen-based tissue sealant to seamlessly connect human or animal tissues or organ parts, to seal wounds, stop bleeding and the like by mixing fibrin or fibrinogen with blood clot-promoting coagulation factors are disclosed. The device includes two cylindrical compartments for separately containing the separate fluid components of the sealant preparation, which are simultaneously displaced from the respective compartments by plungers commonly depressable with the same effective strokes. The plungers may be depressed directly or by a common mechanism (e.g., rack and pinion) for accurately controlling the rate of dispensing fluid. The cylindrical compartments are of the same or different cross-sectional area and are arranged either concentrically or side-by-side. The device further includes structure for merging the two fluid components within an outer sleeve housing an inner needle. The sleeve and needle contain conduits for the flow of the two fluid sealant components as they are expressed from the respective compartments. Also disclosed are a convenient device for filling the two compartments, structure for mixing the fluid components, and for atomizing the effluent sealant fluid stream (i.e., spraying).

The invention provide a new lens curing method for making hydrogel contact lenses. The new lens curing method is based on actinically-induced step-growth polymerization. The invention also provides hydrogel contact lenses prepared from the method of the invention and fluid compositions for making hydrogel contact lenses based on the new lens curing method. In addition, the invention provide prepolymers capable of undergoing actinically-induced step-growth polymerization to form hydrogel contact lenses.

In stimulation treatments to increase the production of hydrocarbons from subterranean formations, especially in treatments including hydraulic fracturing followed by gravel packing, desirable short wide fractures are created and filled with proppant by deliberately including in the first fluid / proppant slurry pumped a sufficiently high concentration of a bridging-promoting material, such as fibers, that reduces the mobility of the slurry when it dewaters so that screenout at or near the tip occurs.

Disclosed is a microemulsifying metal-cutting-fluid composition, comprising base oil or oily agent, mixed alcohol-amine, boric acid, anionic surfactant, nonionic surfactant, antirust agent, copper alloy corrosion inhibitor, preservative, deionized water and the like. The invention has the advantages of excellent lubricity, cooling ability, cleaning ability and a long lifetime of metal cutting fluid, being suited to various metal processing technologies such as cutting, reaming, boring, grinding. Also, the wastewater is easy to treat.

Integrated surface-subsurface modeling has been shown to have a critical impact on field development and optimization. Integrated models are often necessary to analyze properly the pressure interaction between a reservoir and a constrained surface facility network, or to predict the behavior of several fields, which may have different fluid compositions, sharing a common surface facility. The latter is gaining a tremendous significance in recent deepwater field development. These applications require an integrated solution with the following capabilities: * to balance a surface network model with a reservoir simulation model in a robust and efficient manner. * To couple multiple reservoir models, production and injection networks, synchronising their advancement through time. * To allow the reservoir and surface network models to use their own independent fluid descriptions (black oil or compositional descriptions with differing sets of pseudo-components). * To apply global production and injection constraints to the coupled system (including the transfer of re-injection fluids between reservoirs). In this paper we describe a general-purpose multi-platform reservoir and network coupling controller having all the above features. The controller communicates with a selection of reservoir simulators and surface network simulators via an open message-passing interface. It manages the balancing of the reservoirs and surface networks, and synchronizes their advancement through time. The controller also applies the global production and injection constraints, and converts the hydrocarbon fluid streams between the different sets of pseudo-components used in the simulation models. The controller's coupling and synchronization algorithms are described, and example applications are provided. The flexibility of the controller's open interface makes it possible to plug in further modules (to perform optimization, for example) and additional simulators.

Oil-based settable spotting fluid compositions and methods of using the compositions are provided. The oil-based settable spotting fluid compositions are basically comprised of oil, an emulsifying surfactant for emulsifying the oil with water whereby an oil-external emulsion is formed, a de-emulsifying surfactant which in time de-emulsifies said oil-external emulsion when the emulsion is contacted with external water, a hydraulic settable component selected from the group consisting of ASTM Class C or the equivalent fly ash and ASTM Class F or the equivalent fly ash together with a source of calcium and water selected from the group consisting of fresh water and salt water.

An aqueous fluid composition useful for the recovery of hydrocarbons from a subterranean formation, including a mixture of water, a water soluble polymer, an inorganic salt and at least one zwitterionic surfactant and methods of using same.

Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic component, such as one or more corticosteroids, a biocompatible polymeric component, and a solvent component. The composition is in a fluid form before placement in the interior of an eye, and becomes less fluid after the composition is placed in the eye to form an extended or delayed release drug delivery element or system. The drug delivery element is formed by the dissipation of the solvent from the composition when the composition is placed in the interior of an eye. One example of a composition includes triamcinolone acetonide as a therapeutic agent. A method of treating an ophthalmic condition, or otherwise improving or enhancing vision of a patient, comprises placing the fluid composition in the interior of the eye. The method may be practiced by injecting the fluid composition into the interior of the eye.

The present invention provides novel “patch in a bottle” technology in which a fluid composition, e.g., an aerosol spray, is applied onto a surface as a fluid, but then dries to form a covering element, such as a patch, having a tack free outer surface covering an underlying adhesive that helps adhere the patch to the substrate. The fluid compositions have a unique chemical formulation that allows such composite patches to form in situ. Specifically, the fluid compositions include a tacky component, such as an adhesive, and a film-forming, non-tacky component. The non-tacky and tacky components are selected to be immiscible with each other so that the components undergo phase separation as the fluid composition dries.

Aqueous well treatment fluid compositions with biocidal activity are disclosed comprising a polymer for modifying fluid viscosity in the aqueous fluid, an organic monocarboxylic peracid being present in an anti-microbial amount of about 1 ppm to about 1000 ppm, and a controlled amount of hydrogen peroxide also being present. Peracetic acid is the preferred peracid. The viscosity-modifying polymer in the aqueous well treatment fluid composition may serve to reduce friction in the fluid or increase fluid viscosity. A method of using such compositions is also disclosed.

A thermodynamic system that produces mechanical, electrical power, and / or fluid streams for heating or cooling. The cycle contains a combustion system that produces an energetic fluid by combustion of a fuel with an oxidant. A thermal diluent may be used in the cycle to improve performance, including but not limited to power, efficiency, economics, emissions, dynamic and off-peak load performance, and / or turbine inlet temperature (TIT) regulation and cooling heated components. The cycle preferably includes a heat recovery system and a condenser or other means to recover and recycle heat and the thermal diluent from the energetic fluid to improve the cycle thermodynamic efficiency and reduce energy conversion costs. The cycle may also include controls for temperatures, pressures, and flow rates throughout the cycle, and controls power output, efficiency, and energetic fluid composition.

Described herein are devices, systems, and methods for determining the composition of fluids, and particularly for describing the identity and concentration of one or more components of a medical fluid such as intravenous fluid. These devices, systems and methods take multiple complex admittance measurements from a fluid sample in order to identify the identity and the concentration of components of the fluid. The identity and concentration of all of the components of the solution may be simultaneously and rapidly determined. In some variations, additional measurement or sensing modalities may be used in addition to admittance spectroscopy, including optical, thermal, chemical, etc.

Provided are electrokinetically-altered fluids (gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for using same in treating cystic fibrosis or a symptom thereof. The electrokinetically-altered fluid compositions and methods include electrokinetically-altered fluids optionally in combination with other therapeutic agents (e.g., antibiotics, albuterol, budesonide, etc.). Particular embodiments comprise use and / or synergy with tobramycin for treating bacterial infection, and use and / or synergy with a bronchiodilator. In certain aspects, the methods comprise regulating intracellular signal transduction by modulation of at least one of cellular membranes, membrane potential, membrane proteins (like, membrane receptors, including but not limited to G protein coupled receptors, and intercellular junctions).

Treating fluid compositions for use in hydrocarbon recovery operations from subterranean formations are described, as well as methods for their preparation and use. In particular, treating fluid compositions are described which comprise a liquid, a crosslinkable organic polymer material that is at least partially soluble in the liquid, a crosslinking agent that is capable of increasing the viscosity of the treating fluid by crosslinking the organic polymer material in the liquid, and a crosslinking modifier additive which can delay or accelerate the crosslinking of the treating fluid composition. Such compositions may be used in a variety of hydrocarbon recovery operations including fracturing operations, drilling operations, gravel packing operations, water control operations, and the like.

The present invention relates to viscosified treatment fluids used in industrial and oil field operations, and more particularly, to brine-based viscosified treatment fluids comprising xanthan gelling agents, and their use in industrial and oil field operations. In one embodiment, the present invention provides a method of treating a portion of a subterranean formation comprising the steps of: providing a viscosified treatment fluid that comprises a brine and a gelling agent that comprises a clarified xanthan; and treating the portion of the subterranean formation. The present invention also provides methods of fracturing, gravel packing, and making viscosified treatments fluids. Also provided are viscosified treatment fluid compositions, and gelling agent compositions.

Disclosed are methods for treating endoleaks arising from endovascular repair of abdominal aortic aneurysms. The disclosed methods involve the in situ sealing of endoleaks after placement of an endovascular prostheses in the abdominal aorta. Sealing of endoleaks is achieved by injection of either a biocompatible polymer or prepolymer fluid composition into the endoleak which composition in situ solidifies to seal the leak. Preferably, the biocompatible fluid composition comprises a contrast agent to allow the clinician to visualize the sealing process.

The present invention relates to viscosified treatment fluids comprising gelling agents that comprise scleroglucan or diutan, and their use in industrial and oil field operations. In certain embodiments, the present invention provides methods of treating a portion of a subterranean formation with a viscosified treatment comprising a gelling agent that comprises scleroglucan or diutan. Methods of fracturing, gravel packing, and producing hydrocarbons also are provided. Viscosified treatment fluid compositions and methods of making such exemplary compositions are provided as well.

Cavity and sentinel lymph node marking 412 devices, marker delivery devices, and methods are disclosed. More particularly, upon insertion into a body, the cavity marking device and method enable one to determine the center, orientation, and periphery of the cavity by radiographic, mammography, echogenic, or other noninvasive imaging techniques. A composition and method are disclosed for locating the sentinel lymph node in a mammalian body to determine if cancerous cells have spread thereto. The composition is preferably a fluid composition consisting of a carrier fluid and some type of contrast agent; alternatively, the contrast agent may itself be a fluid and therefore not need a separate carrier fluid. This composition is capable of (1) deposition in or around a lesion and migration to and accumulation in the associated sentinel node, and (2) remote detection via any number of noninvasive techniques. Also disclosed is a method for remotely detecting the location of a sentinel node by (1) depositing a remotely detectable fluid in or around a lesion for migration to and accumulation in the associated sentinel node and (2) remotely detecting the location of that node with a minimum of trauma and toxicity to the patient. The composition and method may serve to mark a biopsy cavity, as well as mark the sentinel lymph node. The marking methods also may combine any of the features as described with the marking device and delivery device.

Cationic underprinting fluids, which together with pigment-based ink compositions achieve enhanced durability, chroma, optical density and print quality in inkjet printed images.

A well treatment fluid composition that comprises a carrier fluid and an amphoteric surfactant, and optionally a viscosifying agent and proppant, is well suited for use in fracturing coal beds to stimulate methane production. The composition preferably is a foam that comprises a gas such as nitrogen or air. Preferably, the surfactant has the formulaR—NH2—(CH2)n—C(O)OXwherein R is a saturated or unsaturated alkyl group having from 6-20 carbon atoms, n is from 2-6, and X is hydrogen or a salt forming cation.

A method of measuring fluid properties such as flow velocity, flow rate, and fluid composition comprises positioning a heat exchange element with a temperature sensor, such as an optical fiber temperature sensor, arranged centrally inside the element in thermal contact with a fluid of interest, heating or cooling the heat exchange element to cause a temperature difference and exchange of thermal energy between the element and the fluid, using the temperature sensor to measure the temperature of the heat exchange element during the exchange of thermal energy, and determining properties of the fluid from the temperature measurement. A second temperature sensor can be provided offset from the first sensor to provide additional measurements to improve accuracy, and a plurality of heat exchange elements with temperature sensors can be used together to determine fluid properties over a large region.

Disclosed is an emulsifying metal-cutting-fluid composition comprising base oil or oily agent, mixed alcohol-amine, anionic surfactant, nonionic surfactant, antirust agent, copper alloy corrosion inhibitor, preservative and the like. The invention has a strong general usability, suitable for metal processing, particularly aluminum alloy metal processing with advantages of excellent lubricity, corrosion resistance, a low cost and being free of toxic or harmful substances such as nitrites and phenols, so as to keep the environment and operators away from harmfulness.

The instant invention pertains to a method and a fluid composition for producing contact lenses with relatively high edge quality and with relatively high precision and fidelity in reproducing a desired lens design. The method of the invention involves: a mold which has a first mold half with a first molding surface and a second mold half with a second molding surface, wherein the first and second mold halves are configured to receive each other such that the cavity is formed between the first and second molding surfaces which define the opposite two surfaces of a contact lens to be produced; a spatial limitation of actinic radiation to define the edge of the contact lens to be produced; and addition of a radical scavenger in a fluid composition comprising a lens-forming material to reduce substantially the crosslinking / polymerizing, caused by diffused, scattered and / or reflected incident actinic radiation, of the fluid composition outside of and around the spatial limitation of actinic radiation.

Provided are electrokinetically-altered fluids (e.g., gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for using same in treating digestive disorders or at least one symptom thereof. The electrokinetically-altered fluid compositions and methods include electrokinetically-altered ioinic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said digestive disorders by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids and therapeutic compositions.

Medical apparatus and processes controllably generate medically useful micro or nano bubbles of medically desirable and controllably selectable size, size distribution, homogeneity and concentration (and / or other key bubble parameters) for patient infusion, and / or which may incorporate therapeutic or other agents for patient infusion and / or may be combined with therapeutic or other agents prior to infusion into patients. The bubble generation apparatus and processes controllably permit the adjustment and selection of key bubble parameters through bubble generation actuation and orientation techniques and through selection of bubble fluid compositions in order to facilitate medical research and / or to optimize treatment for imaging, therapy, sonoporation, inertial and non-inertial cavitation, and acoustic activation, among other medical uses. Disposable cartridges containing such bubbles are provided and may include means for patient infusion.

Provided are electrokinetically-altered fluids (gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for using same in treating cystic fibrosis or a symptom thereof. The electrokinetically-altered fluid compositions and methods include electrokinetically-altered fluids optionally in combination with other therapeutic agents (e.g., antibiotics, albuterol, budesonide, etc.). Particular embodiments comprise use and / or synergy with tobramycin for treating bacterial infection, and use and / or synergy with a bronchiodilator. In certain aspects, the methods comprise regulating intracellular signal transduction by modulation of at least one of cellular membranes, membrane potential, membrane proteins (like, membrane receptors, including but not limited to G protein coupled receptors, and intercellular junctions).

Provided are electrokinetically-altered fluids (gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for using same in treating inflammation or at least one symptom thereof. The electrokinetically-altered fluid compositions and methods include electrokinetically-altered ionic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with inflammatory responses by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular routes of administration or formulations for the electrokinetically-generated fluids (electrokinetically-generated gas-enriched fluids and solutions) and therapeutic compositions.